These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1909536)

  • 1. The natural history of untreated phenylketonuria over 20 years.
    Pitt DB; Danks DM
    J Paediatr Child Health; 1991 Jun; 27(3):189-90. PubMed ID: 1909536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation into diet treatment for adults with previously untreated phenylketonuria and severe intellectual disability.
    Fitzgerald B; Morgan J; Keene N; Rollinson R; Hodgson A; Dalrymple-Smith J
    J Intellect Disabil Res; 2000 Feb; 44 ( Pt 1)():53-9. PubMed ID: 10711650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can untreated PKU patients escape from intellectual disability? A systematic review.
    van Vliet D; van Wegberg AMJ; Ahring K; Bik-Multanowski M; Blau N; Bulut FD; Casas K; Didycz B; Djordjevic M; Federico A; Feillet F; Gizewska M; Gramer G; Hertecant JL; Hollak CEM; Jørgensen JV; Karall D; Landau Y; Leuzzi V; Mathisen P; Moseley K; Mungan NÖ; Nardecchia F; Õunap K; Powell KK; Ramachandran R; Rutsch F; Setoodeh A; Stojiljkovic M; Trefz FK; Usurelu N; Wilson C; van Karnebeek CD; Hanley WB; van Spronsen FJ
    Orphanet J Rare Dis; 2018 Aug; 13(1):149. PubMed ID: 30157945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Untreated PKU Patients without Intellectual Disability: What Do They Teach Us?
    van Vliet D; van Wegberg AMJ; Ahring K; Bik-Multanowski M; Casas K; Didycz B; Djordjevic M; Hertecant JL; Leuzzi V; Mathisen P; Nardecchia F; Powell KK; Rutsch F; Stojiljkovic M; Trefz FK; Usurelu N; Wilson C; van Karnebeek CD; Hanley WB; van Spronsen FJ
    Nutrients; 2019 Oct; 11(11):. PubMed ID: 31731404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.
    Boot E; Hollak CEM; Huijbregts SCJ; Jahja R; van Vliet D; Nederveen AJ; Nieman DH; Bosch AM; Bour LJ; Bakermans AJ; Abeling NGGM; Bassett AS; van Amelsvoort TAMJ; van Spronsen FJ; Booij J
    Psychol Med; 2017 Dec; 47(16):2854-2865. PubMed ID: 28552082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of phenylketonuria and influence of early treatment.
    Smith I; Wolff OH
    Lancet; 1974 Sep; 2(7880):540-4. PubMed ID: 4140266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of hyperphenylalaninemia and intellectual outcome in teenagers with phenylketonuria.
    Didycz B; Bik-Multanowski M
    Acta Biochim Pol; 2017; 64(3):527-531. PubMed ID: 28850634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylketonuria is still a major cause of mental retardation in Tunisia despite the possibility of treatment.
    Khemir S; El Asmi M; Sanhaji H; Feki M; Jemaa R; Tebib N; Dhondt JL; Ben Dridi MF; Mebazaa A; Kaabachi N
    Clin Neurol Neurosurg; 2011 Nov; 113(9):727-30. PubMed ID: 21862209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cord-blood tyrosine levels in the full-term phenylketonuric fetus and the "justification hypothesis".
    Scriver CR; Cole DE; Houghton SA; Levy HL; Grenier A; Laberge C
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6175-8. PubMed ID: 6934544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One too many: intellectual disability secondary to undiagnosed phenylketonuria.
    Hui J; Chong SC; Law LK; Lee LK; Chang S; Yau P; Yuen YP
    Hong Kong Med J; 2016 Oct; 22(5):506-8. PubMed ID: 27738300
    [No Abstract]   [Full Text] [Related]  

  • 13. A new therapy prevents intellectual disability in mouse with phenylketonuria.
    Pascucci T; Rossi L; Colamartino M; Gabucci C; Carducci C; Valzania A; Sasso V; Bigini N; Pierigè F; Viscomi MT; Ventura R; Cabib S; Magnani M; Puglisi-Allegra S; Leuzzi V
    Mol Genet Metab; 2018 May; 124(1):39-49. PubMed ID: 29661557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of patients treated for phenylketonuria (PKU). Results from the Prague PKU Center.
    Cechák P; Hejcmanová L; Rupp A
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S59-63. PubMed ID: 8828612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal serum phenylalanine for adult patients with phenylketonuria.
    Okano Y; Nagasaka H
    Mol Genet Metab; 2013 Dec; 110(4):424-30. PubMed ID: 24094552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of a low phenylalanine diet in response to the challenging behaviour of a man with untreated phenylketonuria and profound learning disabilities.
    Harvey EL; Kirk SF
    J Intellect Disabil Res; 1995 Dec; 39 ( Pt 6)():520-6. PubMed ID: 8746739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive profile and mental health in adult phenylketonuria: A PKU-COBESO study.
    Jahja R; Huijbregts SCJ; de Sonneville LMJ; van der Meere JJ; Legemaat AM; Bosch AM; Hollak CEM; Rubio-Gozalbo ME; Brouwers MCGJ; Hofstede FC; de Vries MC; Janssen MCH; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Neuropsychology; 2017 May; 31(4):437-447. PubMed ID: 28318283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of genotype and intellectual phenotype in untreated PKU patients.
    Ramus SJ; Forrest SM; Pitt DB; Saleeba JA; Cotton RG
    J Med Genet; 1993 May; 30(5):401-5. PubMed ID: 8320703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamine depletion in phenylketonuria. A possible cause of the mental defect.
    Perry TL; Hansen S; Tischler B; Bunting R; Diamond S
    N Engl J Med; 1970 Apr; 282(14):761-6. PubMed ID: 5416968
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenylketonuria and anorexia nervosa.
    Clarke DJ; Yapa P
    J Ment Defic Res; 1991 Apr; 35 ( Pt 2)():165-70. PubMed ID: 1906546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.